par Grisar, T;Bottin, P;de Borchgrave d'Alténa, Valérie;Brichart, C;Delcourt, C;Dubru, J M;Foulon, Martine 
;Ghariani, S;Hotermans, Christophe;Legros, Benjamin ;Ossemann, M;Sadzot, B.;Tugendhaft, P;Van Bogaert, Patrick ;van Rijckevorsel, Kenou;Verheulpen, Denis
Référence Acta neurologica belgica, 105, 1, page (5-13)
Publication Publié, 2005-03
;Ghariani, S;Hotermans, Christophe;Legros, Benjamin ;Ossemann, M;Sadzot, B.;Tugendhaft, P;Van Bogaert, Patrick ;van Rijckevorsel, Kenou;Verheulpen, Denis Référence Acta neurologica belgica, 105, 1, page (5-13)
Publication Publié, 2005-03
Article révisé par les pairs
| Résumé : | In many circumstances antiepileptic drugs are used in patients who have never presented any clinical epileptic seizures. These substances are administered on the assumption of a potential risk for the patients of developing acute or delayed chronic seizures after brain injuries such as trauma, stroke, hemorrages or even neurosurgical interventions. The aim of this paper is to propose therapeutic guidelines for the management of this prophylactic attitude in epilepsy based on basic research and clinical practice in the French community in Belgium. We will distinguish between the prevention of acute (early onset-provoked) seizures and a delayed truly post-lesional (unprovoked) epilepsy. Some therapeutic goals can be achieved under the former circumstances whereas in the latter situation we all agree for the absence of any coherent antiepileptic prophylactic behaviour. |
